|
Beaconsfield, D., Ginsburg, J., and Rainsbury, R. "Therapeutic potential of marihuana." New England Journal of Medicine 289(24) 1973: 1315.
Bhargave, H. "Potential therapeutic application of naturally occurring and synthetic cannabinoids." General Pharmacology 9 1978: 195-213.
Council on Scientific Affairs. "Marijuana: Its health hazards and therapeutic potentials." Journal of the American Medical Association 246(16) 1981: 1823-1827.
Grinspoon, L., Bakalar, J. "Marihuana as medicine, a plea for reconsideration." Journal of the American Medical Association 273(23) 1995: 1875-1876.
Hall, WD, Degenhardt, LJ, Currow, D. "Allowing the medical use of cannabis." Medical Journal of Australia 175(1) 2001: 39-40.
Joy, Janet E., Stanley J. Watson, and John A. Benson. Marijuana and medicine: Assessing the science base. Washington, DC: National Academy Press, 1999.
Kassirer, Jerome P., M.D. "Federal Foolishness and Marijuana." New England Journal of Medicine 336(5) 1997: 366-367.
Kumar, RN, Chambers, WA, Pertwee, RG. "Pharmacological actions and therapeutic uses of cannabis and cannabinoids." Anaesthesia 56(11) 2001: 1059-68.
Mechoulam, R, Hanus, L. "Cannabidiol: an overview of some chemical and pharmacological aspects Part I: chemical aspects." Chemistry and Physics of Lipids 121(1-2) 2002: 35-43.
Mikuriya, M.D., Tod, Ed. Marijuana: Medical Papers (1839- 1972). Oakland, Calif.: MediComp Press. 1973. 465 p.
Morgan, David R.; Ashton, C. Eds. "Therapeutic Uses of Cannabis." British Medical Association, Ed. 1998.
Robson, P. "Therapeutic aspects of cannabis and cannabinoids." British Journal of Psychiatry. 178 2001:107- 15.
Schurr, A. "Marijuana: Much ado about THC." Comparative Biochemistry and Physiology 80(1) 1985: 1-7.
Snyder, Solomon H. Marijuana: Its Effects on Mind and Body, Encyclopedia of Psychoactive Drugs. Series 1, 1991.
Taylor, HG. "Analysis of the medical use of marijuana and its societal implications." Journal of American Pharmaceutical Association 38(2) 1998: 220-7.
Ungerleider, J. and Andrysiak, T. "Therapeutic issues of marijuana and THC." International Journal of Addictions 20(5) 1985: 691-699.
Voth, EA, Schwartz, RH. "Medicinal applications of delta-9- tetrahydrocannabinol and marijuana." Annals of Internal Medicine 126(10) 1997: 791-8.
Watson, SJ, Benson JA Jr, Joy JE. "Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report." Archives of General Psychiatry 57(6) 2000: 547-52.
Zinberg, N. "On cannabis and health." Journal of Psychedelic Drugs 11(1-2) 1979: 135-144.
Beal JE, Olson, RLL, Morales, JO, Bellman, P, Yangco, B, Lefkowitz, L, Plasse, TF, Shepard, KV. "Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS." Journal of Pain and Symptom Management 10 1995: 89-97.
Beal JE, Olson, R, Lefkowitz, L, Laubenstein, L, Bellman, P, Yangco, B, Morales, JO, Murphy, R, Powderly, W, Plasse, TF, Mosdell, KW, Shepard, KV. "Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome- associated anorexia." Journal of Pain and Symptom Management 14 1997: 7-14.
Bredt, BM, Higuera-Alhino, D, Shade, SB, Hebert, SJ, McCune, JM, Abrams, DI. "Short-term effects of cannabinoids on immune phenotype and function in HIV-1- infected patients." Journal of Clinical Pharmacology 42(11 Suppl) 2002: 82S-89S.
Haney, M. "Effects of smoked marijuana in healthy and HIV + marijuana smokers." Journal of Clinical Pharmacology 42(11 Suppl) 2002: 34S-40S.
Kosel, BW, Aweeka, FT, Benowitz, NL, Shade, SB, Hilton, JF, Lizak, PS, Abrams, DI. "The effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir." AIDS 16(4) 2002: 543-550.
Kotler, DP, Gaetz, HP, Klein, EB, Lange, M, Holt, PR. "Enteropathy associated with the acquired immunodeficiency syndrome." Annals of Internal Medicine 101 1984: 421-428.
Timpone, JG, Wright, DJ, Li N, Egorin, MJ, Enama, ME, Mayers, J, Galetto, G, DATRI 004 Study Group. "The safety and pharmacokinetics of single-agent and combination therapy with megestrol acetate and dronabinol for the treatment of HIV wasting syndrome: The DATRI 004 study group." AIDS Research and Human Retroviruses 13 1997: 305315.
Cooler, P, Gregg, JM. "Effect of delta-9- tetrahydrocannabinol on intraocular pressure in humans." Southern Medical Journal 70 1977:951-954.
Crawford, WJ, Merritt, JC. "Effects of tetrahydrocannabinol on arterial andintraocular hypertension." International Journal of Clinical Pharmacology and Biopharmacy 17 1979:191-196.
Green, K. "Marijuana smoking vs cannabinoids for glaucoma therapy." Archives of Ophthalmology 116(11) 1998: 1433-1437.
Green, K, Roth M. "Ocular effects of topical administration of delta-9-tetrahydrocannabinol in man." Archives of Ophthalmology 100 1982: 265-267.
Green, L. "Marijuana effects on intraocular pressure." Applied, Pharmacology in the Medical Treatment of Glaucomas 1984: 507-526.
Hepler, RS, Frank, IR. "Marihuana smoking and intraocular pressure." Journal of the American Medical Association 217(10) 1971:1392.
Jay, WM, Green, K. "Multiple-drop study of topically applied 1%, A9-tetrahydrocannabinol in human eyes". Archives of Ophthalmology 101 1983: 591-593.
Jones RT, Benowitz NL, Heming RI. "Clinical relevance of cannabis tolerance and dependence". Journal of Clinical Pharmacology 21 1981:143S-152S.
Kaufman, PL. "Marijuana and glaucoma." Archives of Ophthalmology 116(11) 1998: 1512-1513.
Merritt, J. "Glaucoma, hypertension, and marijuana." Journal of the National Medical Association 74(8) 1982: 715- 716.
Merritt, J. et al. "Topical delta-8-tetrahydrocannabinol as a potential glaucoma agent." Glaucoma 4 1982: 253-255.
Merritt, J., Crawford, W., Alexander, P., Anduze, A. and Gelbart, S. "Effect of marihuana on intraocular and blood pressure in glaucoma." Ophthalmology 87(3) 1980: 222- 228.
Merritt, J., Perry, D., Russell, D. and Jones, B. "Topical delta-9-tetrahydrocannabinol and aqueous dynamics in glaucoma." Journal of Clinical Pharmacology 21(8-9) 1981: 467S-471S.
Porcella, A, Casellas, P, Gessa, GL, Pani, L. "Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana." Brain Research Molecular Brain Research 58(1- 2) 1998: 240-245.
Porcella, A, Maxia, C, Gessa, GL, Pani, L. "The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies." European Journal of Neuroscience 13(2) 2001: 409-412.
Shapiro, D. "The ocular manifestations of the cannabinoids." Opthalmologica 168 1974: 366-369.
Zimmerman, T. "Efficacy in glaucoma treatment -- the potential of marijuana." Annals of Ophthalmology 12(4)1980: 449-450.
Bateman, D.C., Rawlins, M. "Therapeutic potential of cannabinoids." British Medical Journal 284 1982: 1211-1212.
"Cannabinoids for nausea." The Lancet 1(8214) 1981: 255- 256.
Chang, A. et al. "Delta-9-tetrahydrocannabinol as an antiemetic in cancer patients Receiving high- dose methotrexate." Annals of Internal Medicine 91(6) 1979: 819-824.
Doblin, R., Kleiman, M. "Marijuana as antiemetic medicine: A survey of oncologists' experiences and attitudes" Journal of Clinical Oncology 9(7) 1991: 1314-1319.
Gralla, RJ, Tyson, LB, Borden, LB, et al. "Antiemetic therapy: A review of recent studies and a report of a random assignment trial comparing metoclopramide with delta-9-tetrahydrocannabinol." Cancer Treatment Reports 68 1984: 163-172.
Jenkins, P. "Cannabis used in new cancer technology." Financial Times 26 Aug. 2002, late ed.: 18+.
Kutner, Michael H. "Evaluation of the Use of Both Marijuana and THC in Cancer Patients for the Relief of Nausea and Vomiting Associated with Cancer Chemotherapy after Failure of Conventional Anti-Emetic Therapy: Efficacy and Toxicity" as prepared for the Composite State Board of Medical Examiners, Georgia Department of Health, by physicians and researchers at Emory University, Atlanta, (January 20, 1983).
Levitt, M, Faiman, C, Hawks, R, et al. "Randomized double- blind comparison of delta-9-THC and marijuana as chemotherapy antiemetics." Proceedings of the American Society for Clinical Oncology 3 1984: 91.
Noyes R Jr, Brunk, SF, Baram, DA, Canter, A. "Analgesic effect of delta-9-tetrahydrocannabinol." Journal of Clinical Pharmacology 15(2-3) 1975:139-43.
Noyes R Jr, Brunk, SF, Baram, DA, Canter, A. Sallan, S.E., Cronin, C. Zelen, M., Zinberg, N.E. "Antiemetics in patients receiving chemotherapy for cancer: A randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine." New England Journal of Medicine 302(3) 1980: 135-138.
Parker LA, Mechoulam, R,Schlievert,C. "Cannabidiol, a non- psychoactive component of cannabis and its synthetic dimethylheptyl homolog suppress nausea in an experimental model with rats." Neuroreport 13(5) 2002: 567-70.
Parker LA, Mechoulam R, Schlievert, C, Abbott, L, Fudge, ML, Burton, P. "Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea." Psychopharmacology 166(2) 2003: 156-62.
Sallan, S.E., Zinberg, N.E., Ferei, E., III, "Antiemetic effect of delta-9- tetrahydrocannabinol in patients receiving cancer chemotherapy." New England Journal of Medicine 293(16) 1975: 795-797.
Schwartz, RH, Beveridge, RA. "Marijuana as an antiemetic drug: how useful is it today? Opinions from clinical oncologists." Journal of Addictive Diseases 14(1) 1994: 5- 14.
Ungerleider, J., Andrysiak, T., Fairbanks, L., Goodnight, J., Sama, G. and Jamison, K. "Cannabis and cancer chemotherapy: A comparison of oral delta-9-THC and prochlorperazine." Cancer 50(4) 1982: 636-645.
Vinciguerra, V., Moore, T., Brennab, E. "Inhalation marijuana as an antiemetic for cancer chemotherapy." N.Y. State Journal of Medicine 1988: 525-527.
Ames, F. and Cridland, S. "Anticonvulsant effects of cannabidiol." South Africa Medical Journal 69 1986: 14.
Campbell, FA, Tramer, MR, Carroll, D, Reynolds, DJ, Moore, RA, McQuay, HJ. "Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review." British Medical Journal 323(7303) 2001:13-6.
Clifford, D.B. "Tetrahydrocannabinol for tremor in multiple sclerosis." Annals of Neurology 13 1983: 669- 671.
Consroe, P, Musty, R, Rein, J, Tillery,W, Pertwee, R. "The perceived effects of smoked cannabis on patients with multiple sclerosis." European Neurology 38(1) 1997: 44-8.
Consroe, P., Wood, G., and Buchsbaum, H. "Anticonvulsant nature of marijuana smoking." Journal of the American Medical Association 234 1975: 306-307.
Dunn, M. and Davis, R. "The perceived effects of marijuana on spinal cord injured males." Paraplegia 12 1974: 175.
Greenberg HS, Werness, SA, Pugh, JE, Andrus, RO, Anderson, DJ, Domino, EF. "Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers." Clinical Pharmacology and Therapeutics 55 1994: 324-328.
Killestein J, Hoogervorst EL, Reif M, Kalkers NF, Van Loenen AC, Staats PG, Gorter RW, Uitdehaag BM, Polman CH. "Safety, tolerability, and efficacy of orally administered cannabinoids in MS." Neurology 58(9) 2002:1404-7.
Maurer, M., Henn, V., Dittrich A., Hoffamn, A., 1990. "Delta- 9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial." European Archives of Psychiatry and Clinical Neuroscience 240 1990: 1-4.
Meinck, H.M., Schonle, P.W., Conrad, B. 1989. "Effect of Cannabinoids on Spasticity and Ataxia in multiple sclerosis." Journal of Neurology 236: 120-122.
Muller-Vahl, KR, Kolbe, H, Schneider, U, Emrich, HM. "Cannabis in movement disorders." Forsch Komplementarmed 6(Suppl 3) 1999: 23-7.
Petro, D. "Marihuana as a therapeutic agent for muscle spasm of spasticity." Psychosomatics 21 1980: 81, 85.
Petro, D., Ellenberger, C., Jr. "Treatment of human spasticity with delta-9- tetrahydrocannabinol." Journal of Clinical Pharmacology 21(8-9 Suppl.) 1981:413S-416S.
Smith, PF. "Cannabinoids in the treatment of pain and spasticity in multiple sclerosis." Current Opinion in Investigational Drugs 3(6) 2002:859-64.
Turkanis, S., Cely, W., Olsen, D. and Karler, R. "Anticonvulsant properties of cannabinol." Research Communications in Chemical Pathology and Pharmacology 8, 1974: 231-246.
Volicer, L, Stelly, M, Morris, J, McLaughlin, J, Volicer, BJ. "Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease." International Journal of Geriatric Psychiatry 12 1997: 913-919.
|